Regeneron Pharmaceuticals | مبيعات



Sales تغيير تاريخ
AbbVie USD 15.1B 642M 2024-12
Agios Pharmaceuticals USD 10.73M 1.77M 2024-12
Alnylam Pharmaceuticals USD 593.17M 92.25M 2024-12
Amgen USD 9.09B 583M 2024-12
Astellas Pharma JPY 517.41B 54.91B 2024-12
AstraZeneca USD 14.89B 1.32B 2024-12
Biogen USD 2.45B 11.1M 2024-12
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
Gilead Sciences USD 7.57B 24M 2024-12
GlaxoSmithKline GBP 8.12B 108M 2024-12
Incyte USD 1.18B 40.83M 2024-12
Ionis Pharmaceuticals USD 226.58M 92.76M 2024-12
J&J USD 22.52B 49M 2024-12
Kyowa Hakko Kirin JPY 132.76B 2.94B 2024-12
Merck USD 15.62B 1.03B 2024-12
Moderna USD 966M 896M 2024-12
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
Novartis USD 13.15B 330M 2024-12
Novartis USD 13.56B 386M 2024-12
Pfizer USD 17.76B 61M 2024-12
Regeneron Pharmaceuticals USD 3.79B 70M 2024-12
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 11.26B 3.5B 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
Teva Pharmaceutical Industries USD 15.33B 11B 2024-12
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
United Therapeutics USD 735.9M 13M 2024-12
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12



Regeneron Pharmaceuticals مبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Apr 2025.